Cell and Gene Commercialization

  1. 5 Key Challenges In The Development Of CGT 5/28/2024

    By tackling these challenges, organizations can greatly improve their chances of obtaining approval and successfully marketing their CAGT products, thereby advancing healthcare.

  2. 6 Key Elements Of Successful Drug And Device Development In Europe 5/28/2024

    Equip your team with the knowledge and strategies necessary to navigate the complexities of EMEA and country-specific regulations with confidence and clarity.

  3. Dr. Bruce Levine on ISCT and the Future of CAR-T 5/23/2024

    In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more.

  4. Dr. Bruce Levine On ISCT And The Future of CAR-T 5/23/2024

    In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more.

  5. Navigating CGT Commercialization: Key Areas For Success 5/13/2024

    The cutting-edge realm of cell and gene therapy holds immense promise for revolutionizing healthcare, and its successful commercialization hinges on several key factors.

  6. Gene Therapy: Global Market Trends & Notable Developments 5/8/2024

    New market research about the gene therapy market from Markets And Markets reveals insights into macro trends, delivery methods, therapeutic areas, and more.

  7. Pioneering The First Cell Therapy For Solid Tumors 4/26/2024

    I spoke to Iovance Biotherapeutics to learn about the company's preparation leading up to the approval of Amtagvi, the first FDA-approved tumor-infiltrating lymphocyte (TIL) therapy aimed at treating solid tumors.

  8. China's Rising Role On The Global Stage In The Oncology Market 4/23/2024

    The oncology pharma market has largely been dominated by European and U.S. companies. With the ongoing expansion of the Chinese biopharma sector, innovative oncology drugs will emerge from China and compete on the international market.

  9. Why Early Market Access Planning Is Crucial In CGT Commercial Strategy 4/12/2024

    Bringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.

  10. Supply Chain Resilience 4/9/2024

    Ensure a stable and reliable supply of essential medications for patients by proactively addressing pharmaceutical supply chain challenges and embracing innovative risk management strategies.